Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

How Depression and Antidepressant Drugs Work

May 20, 2016 9:35 am | by Penn State | News | Comments

The researchers plan to use their mouse model to better understand how ketamine functions to develop safer alternatives.


New Company Created Novel Technology to Treat Diabetes

May 19, 2016 1:00 pm | by University of Aberdeen | News | Comments

The technology could bring the option of an islet transplant to thousands more patients with type 1 diabetes.


Making Injectable Medicine Safer

May 19, 2016 9:34 am | by University at Buffalo | News | Comments

Researchers have tried to address this problem in two ways, each with varying degrees of success.


Oramed Says Oral Insulin Succeeds in Midstage Type 2 Diabetes Trial

May 19, 2016 9:33 am | by Bill Berkrot, Reuters | News | Comments

The result is likely to surprise many skeptics who did not believe insulin could be delivered orally.


Team Develops New MRSA-Fighting Antibiotic

May 19, 2016 9:33 am | by University of Oklahoma | News | Comments

The new drug to treat MRSA combines traditional Food and Drug Administration-approved antibiotics with the polymer BPEI.


Universal Flu Vaccine Under Development by Oxford Spinout Vaccitech

May 19, 2016 9:32 am | by University of Oxford | News | Comments

Currently, no single vaccine can give immunity against even a majority of circulating flu virus strains.


Small Peptide Therapeutics, Big Analytical Considerations

May 19, 2016 9:12 am | by Bo Kowalczyk, M.S, MBA, Vice President of Business Development, AIT Bioscience | Articles | Comments

Over the past decade, new strategies in peptide design have launched a wave of peptide therapeutics. Currently, there are approximately 140 peptide therapeutics in clinical development with over 500 in preclinical development, and the commercial market for novel innovative peptide therapeutics is expected to increase to $17.0 billion by 2018.


Immune Drug for Deadly Skin Cancer Shows Long-Term Survival

May 19, 2016 9:07 am | by Lindsay Tanner, AP Medical Writer | News | Comments

A new kind of drug for the deadliest form of skin cancer helped some patients survive for at least three years, a study shows. 


BMS Announces Positive Phase 3 Study Results for Opdivo

May 19, 2016 8:33 am | News | Comments

Findings to be presented at the meeting will also include additional research to explore biomarkers that may help predict outcomes with Opdivo.


Roche Wins FDA Approval for Bladder Cancer Immunotherapy

May 19, 2016 8:21 am | by Ryan Bushey, Digital Editor | Articles | Comments

The drug is expected to bring around $2.5 billion in annual sales by 2020. 


Large HIV Vaccine Study Planned in South Africa

May 19, 2016 8:00 am | by The Associated Press | News | Comments

Scientists are planning a major study of an experimental HIV vaccine in South Africa later this year.


Antidote to Opioid Drug Overdoses Could Become More Accessible

May 19, 2016 7:30 am | by American Chemical Society | News | Comments

Over the past 15 years, deaths caused by heroin and prescription opioid overdoses have quadrupled despite the existence of a highly effective antidote.


Collaborating to Explore Cancer Therapy Resistance

May 18, 2016 2:00 pm | by Northwestern University | News | Comments

The strategy has potential for use in treating other cancers.


High Levels of Protein p62 Predict Liver Cancer Recurrence

May 18, 2016 11:49 am | News | Comments

Researchers at University of California San Diego School of Medicine and Sanford Burnham Prebys Medical Discovery Institute have discovered that high levels of the protein p62 in human liver samples are strongly associated with cancer recurrence and reduced patient survival. 


AstraZeneca’s Lynparza Fails in Gastric Cancer Phase 3 Trial

May 18, 2016 9:35 am | by Stephanie Guzowski, Editor | News | Comments

AstraZeneca announced Wednesday that its recently approved ovarian cancer treatment Lynparza (olaparib) missed a primary endpoint of improving overall survival in patients with advanced gastric cancer.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.